UMR INSERM 1246 - SPHERE
MethodS in Patients-centered outcomes
and HEalth ResEarch

INSERM

Univ Nantes

Univ Tours

Research

Topics Publications In progress publications Communications

Packages

AnaQol Project PRO-online R Packages Online R-package

Life of the unit

Projects Collaborations PhD thesis Traineeships Traineeships propositions Seminars

Next seminars

Last publications

02 septembre 2020 Devos G, Clark L, Bowden-Jones H, Grall-Bronnec M, Challet G, Khazaal Y, Maurage P, Billieux J (2020) The joint role of impulsivity and distorted cognitions in recreational and problem gambling: A cluster analytic approach. Journal of Affective Disorders(127): 473-482.

29 août 2020 Victorri-Vigneau C, Laforgue E, Grall-Bronnec M, Guillou-Landreat M, Rousselet M, Guerlais M, Feuillet F, Jolliet P, FAN network (2020) Are seniors dependent on benzodiazepines? A national clinical survey of substance use disorder . Clinical Pharmacology and Therapeutics: .

12 août 2020 Challet G, Hardouin JB, Thiabaud E, Saillard A, Donnio Y, Grall-Bronnec M, Perrot B (2020) Early gambling behaviors of newly registered online lottery gamblers: longitudinal analysis using gambling tracking data. J Med Internet Res, 22(8): e17675.

07 août 2020 Cholet J, Rousselet M, Donnio Y, Burlot M, Pere M, Lambert S, Rocher B, Chirio-Espitalier M, Eyzop E, Grall-Bronnec M (2020) Evaluation of cognitive impairment in a French sample of patients with restrictive anorexia nervosa: two distinct profiles emerged with differences in impaired functions and psychopathological symptoms. Eat Weight Disord: Online.

22 juillet 2020 Schreck B, Guerlais M, Laforgue E, Bichon C, Grall-Bronnec M, Victorri-Vigneau C (2020) Cathinone Use Disorder in the Context of Slam Practice: New Pharmacological and Clinical Challenges . Frontiers in Psychiatry, 11: 705.

Updated

10 septembre 2020

Annie-Pierre Jonville-Bera

Situation

Poste : PH Pharmacologie
Institution : CHU de Tours

Publications scientifiques

Articles dans une revue internationale

1. Barthez S, Revet A, Chouchana L, Jonville-Bera AP, Pizzoglio V, Raynaud J, Chebane L, Lapeyre-Mestre M, Montastruc F (2020) Adverse Drug Reactions in Infants, Children and Adolescents Exposed to Antidepressants: A French Pharmacovigilance Study . Eur J Clin Pharmacol: doi: 10.1007/s00228-020-02944-7. Online ahead of print.
2. Larrouquere L, Gabin M, Poingt E, Mouffak A, Hlavaty A, Lepelley M, Khouri C, Bellier A, Alexandre J, Bedouche P, Bertoletti L, Bordet R, Bouhanick B, Jonville-Bera AP, Laporte S, Le Jeunne C, Letinier L, Micallef J, Naudet F, Roustit M, Molimard M, Richard V, Cracowski J (2020) Genesis of an Emergency Public Drug Information Website by the French Society of Pharmacology and Therapeutics During the COVID-19 Pandemic . Fundam Clin Pharmacol, 34(3389): .
3. Simon C, Maurier A, Gaboriau L, Vrignaud L, Dayani P, Vaillant T, Andrée Bos-Thompson M, Jonville-Bera AP (2020) Incidence and Characteristics of Intravascular Pulmonary Migration of Etonogestrel Implants: A French Nationwide Study. Contraception: S0010-7824(20)30154-2. doi: 10.1016/j.contraception.2020.05.006.
4. Bayer G, Agier MS, Lioger B, Lepelley M, Zenut M, Lanoue M, Maillot F, Jonville-Bera AP (2019) Rituximab-induced serum sickness is more frequent in autoimmune diseases as compared to hematological malignancies: A French nationwide study. Eur J Intern Med, 67: 59-64.
5. Chabbert-Buffet N, Marret H, Agostini A, Cardinale C, Hamdaoui N, Hassoun D, Jonville-Bera AP, Lambert M, Linet T, Pienkowski C, Plu-Bureau G, Pragout D, Robin G, Jablonski C, Scheffler M, Vidal V, Vigoureux S, Hédon B (2019) Clinical practice guidelines for contraception by the French National College of Gynecologists and Obstetricians (CNGOF). J Gynecol Obstet Hum Reprod, 48(7): 441-54.
6. Marcé D, Cornillier H, Denis C, Jonville-Bera AP, Machet L (2019) Partial response of metastatic melanoma to BRAF-inhibitor-monotherapy in a pregnant patient with no fetal toxicity. Melanoma Res, 29(4): 446-7.
7. Machet P, Marcé D, Ziyani Y, Dumont M, Cornillier H, Jonville-Bera AP, Machet L (2019) Acute generalized exanthematous pustulosis induced by iomeprol with cross-reactivity to other iodinated contrast agents and mild reaction after rechallenge with iopromide and oral corticosteroid premedication. Contact Dermatitis, 81(1): 74-6.
8. Cornillier H, Giraudeau B, Samimi M, Munck S, Hacard F, Jonville-Bera AP, Jegou M, d'Acremont G, Pham B, Chosidow O, Maruani A (2019) Effect of Diet in Chronic Spontaneous Urticaria: A Systematic Review. Acta Derm Venereol, 99(2): 127-32.
9. Danet C, Araujo M, Bos-Thompson M, Portolan G, Gautier S, Vanlemmens L, Bonenfant S, Jonville-Bera AP, Cottin J, Vial T, Bavoux F, Montastruc JL, Damase-Michel C, Benevent J, Bourgeois-Mondon I, Lacroix I (2018) Pregnancy outcomes in women exposed to cancer chemotherapy. Pharmacoepidemiol Drug Saf, 27(12): 1302-8.
10. Petitpain N, Argoullon L, Masmoudi K, Fedrizzi S, Cottin J, Latarche C, Mertes P, Gillet P, French Network of Regional Pharmacovigilance Centres (2018) Neuromuscular blocking agents induced anaphylaxis: Results and trends of a French pharmacovigilance survey from 2000 to 2012. Allergy, 73(11): 2224-33.
11. Sabatier R, Nicolas E, Paciencia M, Jonville-Bera AP, Madroszyk A, Cecile M, Braticevic C, Duran S, Tassy L, Rouby F, Micallef J, Rousseau F (2018) Nivolumab in routine practice for older patients with advanced or metastatic non-small cell lung cancer. J Geriatr Oncol, 9(5): 494-500.
12. Ponard A, Ferreira-Maldent N, Ertault M, Delain M, Amraoui K, Regina S, Jonville-Bera AP, Hérault O, Colombat P, Gyan E (2018) Glycemic dysregulation in a patient with type 2 diabetes treated with 5-azacitidine: a case report. J Med Case Rep, 12(1): 199. doi: 10.1186/s13256-018-1690-3.
13. Maruani A, Boccara O, Bessis D, Guibaud L, Vabres P, Mazereeuw-Hautier J, Barbarot S, Chiaverini C, Blaise S, Droitcourt C, Mallet S, Marlin S, Lorette G, Woillard J, Jonville-Bera AP, Rollin J, Gruel Y, Herbreteau D, Goga D, Le Touze A, Leducq S, Gissot V, Morel B, Tavernier E, Giraudeau B, Groupe de Recherche de la Société Française de Dermatologie Pédiatrique (2018) Treatment of voluminous and complicated superficial slow-flow vascular malformations with sirolimus (PERFORMUS): protocol for a multicenter phase 2 trial with a randomized observational-phase design. Trials, 19(1): 340;doi: 10.1186/s13063-018-2725-1.
14. Cornillier H, Giraudeau B, Munck S, Hacard F, Jonville-Bera AP, d'Acremont G, Pham B, Maruani A (2018) Chronic spontaneous urticaria in children - a systematic review on interventions and comorbidities. Pediatr Allergy Immunol, 29(3): 303-10.
15. Bailly E, Von Tokarski F, Beau-Salinas F, Picon L, Miquelestorena-Standley E, Rousseau G, Jonville-Bera AP, Halimi JM (2018) Interstitial Nephritis Secondary to Vedolizumab Treatment in Crohn Disease and Safe Rechallenge Using Steroids: A Case Report. Am J Kidney Dis, 71(1): 142-5.
16. Bouquet E, Jourdain M, Machet M, Beau-Salinas F, Jonville-Bera AP (2017) Dasatinib-associated follicular lymphoid hyperplasia: First pediatric case report and literature review. Pediatr Blood Cancer, 64(11): doi: 10.1002/pbc.26597. Epub 2017 Apr 25.
17. Le Moigne M, Bulteau S, Grall-Bronnec M, Gerardin M, Fournier J, Jonville-Bera AP, Jolliet P, Dreno B, Victorri-Vigneau C (2017) Psychiatric disorders, acne and systemic retinoids: comparison of risks. Expert Opin Drug Saf, 16(9): 989-95.
18. Cornillier H, Kervarrec T, Tabareau-Delalande F, Mammou S, Jonville-Bera AP, Machet L (2016) Interstitial granulomatous dermatitis occurring in a patient with SAPHO syndrome one month after starting leflunomide, and subsequently disappearing with ustekinumab. Eur J Dermatol, 26(6): 614-5.
19. Agier MS, Boivin N, Maruani A, Giraudeau B, Gouraud A, Haramburu F, Jean-Pastor M, Machet L, Jonville-Bera AP (2016) Risk assessment of drug-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a disproportionality analysis using the French Pharmacovigilance Database. Br J Dermatol, 175(5): 1067-9.
20. Kaguelidou F, Beau-Salinas F, Jonville-Bera AP, Jacqz-Aigrain E (2016) Neonatal adverse drug reactions: an analysis of reports to the French pharmacovigilance database. Br J Clin Pharmacol, 82(4): 1058-68.
21. Winterfeld U, Merlob P, Baud D, Rousson V, Panchaud A, Rothuizen L, Bernard N, Vial T, Yates L, Pistelli A, Ellfolk M, Eleftheriou G, de Vries L, Jonville-Bera AP, Kadioglu M, Biollaz J, Buclin T (2016) Pregnancy outcome following maternal exposure to pregabalin may call for concern. Neurology, 86(24): 2251-7.
22. Nadal M, Giraudeau B, Tavernier E, Jonville-Bera AP, Lorette G, Maruani A (2016) Efficacy and Safety of Mammalian Target of Rapamycin Inhibitors in Vascular Anomalies: A Systematic Review. Acta Derm Venereol, 96(4): 448-52.
23. Marret H, Simon E, Beucher G, Dreyfus M, Gaudineau A, Vayssière C, Lesavre M, Pluchon M, Winer N, Fernandez H, Aubert J, Bejan-Angoulvan T, Jonville-Bera AP, Clouqueur E, Houfflin-Debarge V, Garrigue A, Pierre F, Collège National des Gynécologues Obstétriciens Français (2015) Overview and expert assessment of off-label use of misoprostol in obstetrics and gynaecology: review and report by the Collège national des gynécologues obstétriciens français. Eur J Obstet Gynecol Reprod Biol, 187: 80-4.
24. Bénard-Laribière A, Miremont-Salamé G, Perault-Pochat M, Noize P, Haramburu F, EMIR Study Group on behalf of the French network of Pharmacovigilance Centres (2015) Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study. Fundam Clin Pharmacol, 29(1): 106-11.

Chapitres d'ouvrage

1. Damase-Michel C, Jean-Pastor M, Jolliet P, Jonville-Bera AP, Lacroix I, Louvigne C, Parry E (2012) Chapitre 15 – Infectiologie : 15.1 Antibiotiques. . In « Médicaments et grossesse : prescrire et évaluer le risque » Annie-Pierre Jonville-Béra, Thierry Vial Edition Elsevier Masson (): 0.
2. Louvigne C, Jolliet P, Jonville-Bera AP (2012) Chapitre 20 – Pneumologie. In Participation à un livre : « Médicaments et grossesse : prescrire et évaluer le risque » Annie-Pierre Jonville-Béra, Thierry Vial Edition Elsevier Masson (): 0.

Articles dans une revue nationale

1. AbouTaam M, Jacquot B, Ferard C, Thery A, Grandvuillemin A, Jonville-Bera AP, Perault-Pochat M, Réseau Français des Centres Régionaux de Pharmacovigilance (2020) The French Pharmacovigilance Surveys: A French Distinctiveness, a Real Input . Therapie: S0040-5957(20)30101-3. doi: 10.1016/j.therap.2020.05.011..
2. Micallef J, Soeiro T, Jonville-Bera AP, French Society of Pharmacology, Therapeutics (SFPT) (2020) Non-steroidal Anti-Inflammatory Drugs, Pharmacology, and COVID-19 Infection . Therapie: S0040-5957(20)30092-5. doi: 10.1016/j.therap.2020.05.003.
3. Lacroix C, Mallaret M, Jonville-Bera AP (2020) Pharmacovigilance and Drug-Induced Rare Diseases: Strengths of the French Network of Regional Pharmacovigilance Centres. Therapie, 75(2): 207-13.
4. Agier MS, Chollet N, Bediou E, Boyer Gervoise M, Jonville-Bera AP (2019) Transient major hypothermia associated with acetaminophen: A pediatric case report and literature review. Arch Pediatr, 26(6): 358-60.
5. Vrignaud L, Simon C, Agier MS, Théophile H, Gras-Champel V, Beau-Salinas F, Lengellé C, Jonville-Bera AP (2019) [Alitretinoin (Toctino®): A French follow-up study of harmacovigilance]. Thérapie: pii: S0040-5957(19)30049-6. doi: 10.1016/j.therap.2019.02.006. [Epub ahead of print].
6. Chabbert-Buffet N, Marret H, Agostini A, Cardinale C, Hamdaoui N, Hassoun D, Jonville-Bera AP, Lambert M, Linet T, Pienkowski C, Plu-Bureau G, Pragout D, Robin G, Rousset-Jablonski C, Scheffler M, Vidal F, Vigoureux S, Hédon B (2018) Contraception: CNGOF Guidelines for Clinical Practice (Short Version). Gynecol Obstet Fertil Senol, 46(12): 760-76.
7. Bernier M, Jonville-Bera AP (2018) Drug and food interactions with contraceptives: CNGOF Contraception Guidelines. Gynecol Obstet Fertil Senol, 46(12): 786-91.
8. Alami Z, Agier MS, Ahid S, Vial T, Dautriche A, Lagarce L, Toutain A, Cherrah Y, Jonville-Bera AP (2018) Pregnancy outcome following in utero exposure to azathioprine: A French comparative observational study. Therapie, 73(3): 199-207.
9. Jonville-Bera AP (2018) [The pictogram "Drug and Pregnancy" : Good intentions but difficulties in sight]. Gynecol Obstet Fertil Senol, 46(5): 455-7.
10. Bouquet E, Star K, Jonville-Bera AP, Durrieu G (2018) Pharmacovigilance in pediatrics. Therapie, 73(2): 171-80.
11. Jonville-Bera AP (2018) [The methods of French pharmacovigilance often criticized, but not yet equaled]. Rev Prat, 68(4): 363-5.
12. Simon C, Lengellé C, Agier MS, Beau-Salinas F, Vrignaud L, Jonville-Bera AP (2017) [Drugs news]. Arch Pediatr, 24(11): 1150-7.
13. Beau-Salinas F, Bouquet E, Vrignaud L, Simon C, Agier MS, Jonville-Bera AP (2017) [Drugs news]. Arch Pediatr, 24(9): 906-7.
14. Vrignaud L, Simon C, Agier MS, Bejan-Angoulvant T, Bouquet E, Beau-Salinas F, Jonville-Bera AP (2017) [Drugs news]. Arch Pediatr, 24(8): 783-7.
15. Beau-Salinas F, Bouquet E, Vrignaud L, Simon C, Agier MS, Jonville-Bera AP (2017) [Drugs news]. Arch Pediatr, 24(5): 501-6.
16. Agier MS, Marchand S, Paret N, Gautier S, Jonville-Bera AP (2017) [Post-licensure safety surveillance for Prevenar 13® in France]. Arch Pediatr, 24(5): 439-44.
17. Weber E, Moulis G, Mahévas M, Guy C, Lioger B, Durieu I, Hunault M, Ramanantsoa M, Royer B, Default A, Perault-Pochat M, Moachon L, Bernard N, Bardy G, Jonville-Bera AP, Geniaux H, Godeau B, Cathébras P (2017) [Thrombosis during thrombopoietin receptor agonist treatment for immune thrombocytopenia. A French multicentric observational study]. Rev Med Interne, 38(3): 167-75.
18. Agier MS, Beau-Salinas F, Bejan-Angoulvant T, Lengellé C, Jonville-Bera AP (2017) [Drugs news]. Arch Pediatr, 24(1): 81-6.
19. Agier MS, Lengellé C, Bejan-Angoulvant T, Beau-Salinas F, Jonville-Bera AP (2016) [Drugs news]. Arch Pediatr, 23(11): 1204-16.
20. Simon C, Agier MS, Béné J, Muller C, Vrignaud L, Marret H, Jonville-Bera AP (2016) [Safety profile of etonogestrel contraceptive implant (Nexplanon® and Implanon®) reported in France]. J Gynecol Obstet Biol Reprod, 45(9): 1074-82.
21. Agier MS, Beau-Salinas F, Lengellé C, Bejan-Angoulvant T, Jonville-Bera AP (2016) [Drugs news]. Arch Pediatr, 23(9): 1002-5.
22. Jonville-Bera AP, Mallaret M, Sgro C, Association Française des Centres Régionaux de Pharmacovigilance (2016) [The congress of the French Society of Pharmacology and Therapeutics celebrate in Nancy, 20 April 2016, 40 years of French Regional Pharmacovigilance Centres!]. Thérapie, 71(4): 351-4.
23. Beau-Salinas F, Lengellé C, Bejan-Angoulvant T, Agier MS, Jonville-Bera AP (2016) [Drugs news]. Arch Pediatr, 23(6): 646-52.
24. Jonville-Bera AP, Vial T, Sgro C, Mallaret M, Association Française des Centres Régionaux de Pharmacovigilance (2016) [On the absence of reimbursement of rotavirus vaccine in France]. Arch Pediatr, 23(6): 655-7.
25. Lengellé C, Bejan-Angoulvant T, Beau-Salinas F, Jonville-Bera AP (2015) [Drugs news]. Arch Pediatr, 22(11): 1200-6.
26. Maruani A, Carriot M, Jonville-Bera AP, Lorette G, Gissot V, association Recommandations en Dermatologie (aRED) (2015) [Highlight on clinical research in pediatrics]. Ann Dermatol Venereol, 142(6): 446-9.
27. Bejan-Angoulvant T, Crochet J, Jonville-Bera AP (2015) [Calcium channel blockers pharmacology and their use as tocolytics]. J Gynecol Obstet Biol Reprod, 44(4): 305-11.
28. Beau-Salinas F, Lengellé C, Bejan-Angoulvant T, Jonville-Bera AP (2015) [Drugs news]. Arch Pediatr, 22(4): 440-6.
29. Bejan-Angoulvant T, Beau-Salinas F, Lengellé C, Cissoko H, Jonville-Bera AP (2015) [Drugs news]. Arch Pediatr, 22(2): .

Communications scientifiques

Poster dans un colloque national (idpers=1398)

1. Picard S., Leven C., Jonville-Bera A.P., Riche C., Perault-Pochat M., Lainé-Cessac P., Coquerel A., Jolliet P., Renaudineau E. Etude prospective sur les néphropathies immunoallergiques (NIA) médicamenteuses dans 11 unités françaises de néphrologie. 9ème Congrès de Physiologie de Pharmacologie et de thérapeutique, Poitiers, 22-24 avril 2014, 2014.